Scientists seek clues to predict which pancreatic cancer treatments will work
NCT ID NCT07326150
Summary
This study aims to create a tool that can predict how well a pancreatic cancer patient will respond to a combination of chemotherapy, immunotherapy, and targeted drugs. Researchers will analyze tissue samples from 70 patients to find biological markers linked to treatment success. The goal is to help doctors choose the most effective treatment plan for each patient in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER RESECTABLE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital)
Zhejiang, Hangzhou, 310022, China
Conditions
Explore the condition pages connected to this study.